Our Pricing

Acid Reflux Treatment Options UK

Published on: June 03, 2026

Finding effective acid reflux treatment UK online doesn't need to be complicated. At Cured Pharmacy, we offer a full range of proton pump inhibitors (PPIs) and acid-reducing medications from £9.99, with free clinical assessment by UK prescribers and discreet next-day delivery across the UK.

Understanding Acid Reflux and GORD

Acid reflux occurs when stomach acid flows back into the oesophagus, causing the characteristic burning sensation known as heartburn. When this happens frequently — typically twice weekly or more — it's classified as gastro-oesophageal reflux disease (GORD), a chronic condition affecting approximately 20% of adults in the UK [1].

The lower oesophageal sphincter (LES), a ring of muscle at the base of the oesophagus, normally prevents acid from rising. When this sphincter weakens or relaxes inappropriately, stomach contents can reflux upward, particularly after large meals, when lying down, or in individuals with a hiatus hernia [1]. Left untreated, chronic acid exposure may lead to oesophagitis, Barrett's oesophagus, or strictures.

Symptoms extend beyond heartburn and may include regurgitation of food or sour liquid, difficulty swallowing, chronic cough, disrupted sleep, and dental erosion. These symptoms significantly impact quality of life, with studies showing GORD patients report lower wellbeing scores than those with untreated hypertension [2].

How Proton Pump Inhibitors Work for Acid Reflux

Proton pump inhibitors (PPIs) are the most effective class of medication for acid reflux, reducing stomach acid production by up to 90% [3]. They work by irreversibly blocking the hydrogen-potassium ATPase enzyme system (the 'proton pump') in gastric parietal cells, which is responsible for secreting hydrochloric acid into the stomach.

Unlike antacids that neutralise existing acid or H2 receptor antagonists that block histamine pathways, PPIs provide superior acid suppression and longer-lasting relief. Clinical trials demonstrate that PPIs heal oesophagitis in 80-90% of patients within 8 weeks, compared to 50-60% with H2 antagonists [3][4].

PPIs require activation in the acidic environment of parietal cell canaliculi, which is why they're most effective when taken 30-60 minutes before meals. Maximum acid suppression typically occurs after 3-5 days of consistent use, as the medication needs time to inhibit newly formed proton pumps.

First-Generation vs Second-Generation PPIs

First-generation PPIs like omeprazole and lansoprazole have been available since the 1980s and remain highly effective for most patients. Second-generation options such as esomeprazole (the S-isomer of omeprazole) and pantoprazole offer improved pharmacokinetics, with more predictable absorption and reduced drug-drug interactions in some cases [4]. Your UK prescriber will recommend the most appropriate option based on your medical history, concurrent medications, and response to previous treatments.

Comparing Acid Reflux Medications Available in the UK

Omeprazole remains the most widely prescribed PPI in the UK, with decades of safety data and proven efficacy across all severities of GORD. Available in 10mg and 20mg strengths, it's typically initiated at 20mg once daily, taken before breakfast. Generic omeprazole offers excellent value whilst branded Losec provides the original formulation for patients who prefer established brands.

Lansoprazole, available in 15mg and 30mg capsules, demonstrates comparable efficacy to omeprazole with slightly faster onset of action in some patients. The orodispersible Zoton FasTab formulation dissolves on the tongue without water, making it ideal for patients with swallowing difficulties or those requiring nasogastric administration.

Esomeprazole (branded as Nexium) provides more consistent acid control due to its single-isomer formulation, which may benefit patients with inadequate response to other PPIs. Pantoprazole offers a favourable safety profile with fewer cytochrome P450 interactions, making it preferable for patients on multiple medications. Pyrocalm (omeprazole 20mg) is available over the counter for short-term relief of reflux symptoms in adults over 18.

Choosing the Right Treatment Strength

NICE guidelines recommend starting with standard doses — omeprazole 20mg, lansoprazole 30mg, esomeprazole 20mg, or pantoprazole 20mg — for 4-8 weeks initially [5]. Patients with severe oesophagitis or Barrett's oesophagus may require higher doses or twice-daily administration. After symptom resolution, step-down therapy to the lowest effective dose minimises long-term exposure whilst maintaining symptom control. Your prescriber will tailor the dose and duration to your specific clinical presentation.

Who Can Use Acid Reflux Treatment

PPIs are suitable for most adults experiencing frequent heartburn, regurgitation, or diagnosed GORD. They're particularly beneficial for patients with erosive oesophagitis, Barrett's oesophagus requiring long-term acid suppression, or reflux symptoms affecting sleep and daily activities.

Certain patients require additional consideration before starting PPI therapy. Those with alarm symptoms — dysphagia, unintentional weight loss, persistent vomiting, gastrointestinal bleeding, or anaemia — should undergo endoscopic investigation before treatment initiation [5]. Patients over 55 with new-onset dyspepsia also warrant further assessment to exclude malignancy.

PPIs are generally safe in pregnancy (particularly omeprazole and lansoprazole) when benefits outweigh risks, though lifestyle modifications should be attempted first. Breastfeeding mothers can typically use PPIs as minimal amounts pass into breast milk. Patients with severe hepatic impairment may require dose adjustments, whilst those with osteoporosis risk should discuss calcium supplementation with their prescriber.

Potential Side Effects and Long-Term Considerations

Most patients tolerate PPIs exceptionally well, with common side effects being mild and infrequent. These may include headache (affecting 2-5% of users), gastrointestinal disturbances such as nausea, abdominal pain, or altered bowel habits, and occasionally dizziness [3]. These effects typically resolve within the first few weeks of treatment.

Long-term PPI use (beyond 12 months) has been associated with small increased risks of certain conditions in observational studies. These include hypomagnesaemia, vitamin B12 deficiency, increased fracture risk (particularly hip fractures in elderly patients), and microscopic colitis [6]. However, these associations don't prove causation, and for most patients, the benefits of controlling severe reflux outweigh these potential risks.

Recent concerns about increased infection risk (Clostridium difficile, pneumonia) and chronic kidney disease have been reported, though evidence remains inconclusive [6]. The MHRA advises that PPIs should be used at the lowest effective dose for the shortest duration necessary. Patients on long-term therapy should have regular medication reviews with their prescriber to assess ongoing need and consider intermittent or on-demand dosing strategies.

Managing Side Effects

If you experience persistent side effects, contact your prescriber rather than stopping treatment abruptly, as rebound acid hypersecretion can occur. Switching to an alternative PPI often resolves tolerability issues. Patients on long-term therapy should ensure adequate calcium and vitamin D intake, and those with risk factors may benefit from periodic magnesium and B12 monitoring.

Lifestyle Modifications to Enhance Treatment Success

Whilst PPIs effectively reduce acid production, combining medication with lifestyle changes optimises symptom control and may allow dose reduction. Weight loss in overweight patients significantly reduces reflux episodes, with studies showing a 10% weight reduction can improve symptoms by 40% [2].

Dietary triggers vary between individuals, but common culprits include caffeine, alcohol, chocolate, fatty foods, citrus fruits, tomatoes, and spicy dishes. Eating smaller, more frequent meals rather than large portions reduces gastric distension and LES pressure. Avoiding food within 3 hours of bedtime allows gastric emptying before lying down, whilst elevating the head of the bed by 15-20cm uses gravity to prevent nocturnal reflux [5].

Smoking cessation is crucial, as tobacco reduces LES pressure and impairs oesophageal clearance mechanisms. Tight clothing around the abdomen should be avoided, and patients should review medications with their prescriber, as certain drugs (calcium channel blockers, nitrates, benzodiazepines, NSAIDs) can worsen reflux symptoms. These modifications work synergistically with PPI therapy to provide comprehensive symptom management.

Scientific References

1. Sandhu, D. S., & Fass, R. (2018). Current Trends in the Management of Gastroesophageal Reflux Disease. Gut and Liver, 12(1), 7–16. https://doi.org/10.5009/gnl16615 [accessed 13 August 2026]
2. Ronkainen, J., et al. (2005). Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut, 54(11), 1537–1542. https://doi.org/10.1136/gut.2005.071514 [accessed 13 August 2026]
3. Shin, J. M., & Sachs, G. (2008). Pharmacology of Proton Pump Inhibitors. Current Gastroenterology Reports, 10(6), 528–534. https://doi.org/10.1007/s11894-008-0098-4 [accessed 13 August 2026]
4. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C19 polymorphisms. Clinical Pharmacology & Therapeutics, 85(3), 296–301. https://doi.org/10.1038/clpt.2008.256 [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2014). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (Clinical guideline CG184). NICE. https://www.nice.org.uk/guidance/cg184 [accessed 13 August 2026]
6. Freedberg, D. E., et al. (2017). The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice. American Journal of Gastroenterology, 112(5), 706–715. https://doi.org/10.1038/ajg.2017.36 [accessed 13 August 2026]
7. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.